65,437 trials
Hypertension
Primary: Proportion of the Physicians' Patients With Blood Pressure Control or Appropriate Response to Uncontrolled Blood Pressure — 75; 80; 79; 86 percentage of physicians'…
Hypertension, · Hyperlipidemia
Primary: sitDBP Changes at Week 8 From Baseline — -9.24; -2.9 mmHg
Obstructive Sleep Apnea
Primary: Apnea Hypopnea Index — 66 percentage of subjects responding
Cigarette Smoking Toxicity
Primary: Smoking Topography- Puff Volume — 518; 661; 650; 620 mL
Metastatic Breast Cancer
Primary: Progression-free Survival (PFS) — 4.4 Months
Urinary Tract Infection
Primary: Proanthocyanidin A2 — 0.6; 0.20 ng/mg creatinine
Stress Disorders, Post-Traumatic
Primary: Change From Baseline in PTSD Checklist - Civilian Version (PCL-C) Score — -18.8; -5.2; 21.8 scores on a scale — p=<0.01
Peripheral Arterial Disease
Primary: Number of Participants With All-cause Mortality, Cardiovascular Mortality, Stroke, and Myocardial Infarctions — 4; 5 participants
Lymphoma, Follicular
Primary: Overall Response Rate (ORR), the Percentage of Patients Who Experience an Objective Benefit From Treatment — 42; 48 percentage of participants
Obesity · Binge Eating
Primary: Binge Eating (Remission) — 10; 8; 6; 6 participants — p=0.60
Netherton Syndrome
Primary: Blood Pimecrolimus Levels — 0; 0; 0.312; 1.260 ng/mL
Congenital Venous Malformation
Primary: Systemic Exposure to Ethanol With the Two Test Products: Determination of the Maximum Plasma Concentration (Cmax) — 0.0604; 0.202 g/L
Partial Epilepsy
Primary: Cmax - Maximum Observed Plasma Concentration — 82.4; 75.0; 4170; 4340 pg/mL
Skin Laxity
Primary: Rate of Collagen Synthesis — 15.71; 21.22; 36.11; 51.80 percentage of new collagen synthesized
Normal Tension Glaucoma
Primary: Intraocular Pressure (IOP), Period 1 — 13.72; 13.50; 13.27; 13.36 mmHg — p=0.05